Instinct Bio Technical Company Holdings Inc. (BIOT)
Consumer · NGM
Price as at 30 Sept 2026, 16:31 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Instinct Bio Technical Company Holdings Inc. trades at $0.37. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
Our moat model scores it 5 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
About Instinct Bio Technical Company Holdings Inc.
Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution. It has a strategic collaboration with PT Parva Candela to develop cosmetics business in Indonesia. The company was founded in 2011 and is headquartered in Tokyo, Japan.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
BIOT peers
The largest companies in the same industry (Household & Personal Products), then in the same sector.
- PG The Procter & Gamble Company
- ULVR.L Unilever PLC
- PUGBY PUIG BRANDS S A
- ELF e.l.f. Beauty, Inc.
- IPAR Interparfums, Inc.
- NWL Newell Brands Inc.
- SPB Spectrum Brands Holdings, Inc.
- ODD Oddity Tech Ltd.
Every consumer company we cover is on the Consumer hub.
Common questions
Where does SteadyShares get its BIOT data?
Fundamentals for BIOT come from company filings and exchange data, as listed on NGM; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 16:31 UTC and is delayed. Our data quality score for this company is 29/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for BIOT, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.